Skip to content

Platform randomised trial of treatments for COVID-19 in general practice

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-501559-99-00
Acronym
NL79504.068.21
Enrollment
682
Registered
2023-03-06
Start date
2023-05-25
Completion date
2023-11-01
Last updated
2023-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with symptomatic COVID-19 in the community and in primary care, who are at higher risk of a complicated illness course.

Brief summary

The primary endpoint is time to recovery from suspected COVID-19 infection within 28 days from randomisation, defined as the first instance that a participant reports feeling recovered. This will be measured by means of a daily diary, where the participant records the answer to the question ‘Do you feel fully recovered today? (i.e. symptoms associated with illness are no longer a problem)’ with either yes or no.

Detailed description

hospital admission, hospital assessment without admission, oxygen administration, Intensive Care Unit admission, duration of severe symptoms, sustained recovery, contacts with the health services, consumption of antibiotics, quality of life, daily rating of how well participant feels, safety, death, long term symptoms, post-COVID-19 functional status

Interventions

DRUGFILMOMHULDE TABLETTEN

Sponsors

Maastricht University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The primary endpoint is time to recovery from suspected COVID-19 infection within 28 days from randomisation, defined as the first instance that a participant reports feeling recovered. This will be measured by means of a daily diary, where the participant records the answer to the question ‘Do you feel fully recovered today? (i.e. symptoms associated with illness are no longer a problem)’ with either yes or no.

Secondary

MeasureTime frame
hospital admission, hospital assessment without admission, oxygen administration, Intensive Care Unit admission, duration of severe symptoms, sustained recovery, contacts with the health services, consumption of antibiotics, quality of life, daily rating of how well participant feels, safety, death, long term symptoms, post-COVID-19 functional status

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026